4.7 Review

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Journal

STROKE
Volume 46, Issue 7, Pages 2032-2060

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STR.0000000000000069

Keywords

AHA Scientific Statements; blood pressure; coagulopathy; diagnosis; intracerebral hemorrhage; intraventricular hemorrhage; surgery; treatment

Funding

  1. NIH/NINDS
  2. Avid Radiopharmaceuticals
  3. NIH
  4. NINDS
  5. National Health and Medical Research (NHMRC) of Australia
  6. NIH/NHLBI
  7. CSL Behring
  8. Brain Aneurysm Foundation
  9. Canadian Institutes of Health Research
  10. Heart and Stroke Foundation of Canada
  11. Physicians Services Incorporated Foundation
  12. NINDS [NS030678, NS036695, 1U01NS069763, NINDS 2P50NS044283]
  13. Novo Nordisk (NINDS)

Ask authors/readers for more resources

Purpose The aim of this guideline is to present current and comprehensive recommendations for the diagnosis and treatment of spontaneous intracerebral hemorrhage. Methods A formal literature search of PubMed was performed through the end of August 2013. The writing committee met by teleconference to discuss narrative text and recommendations. Recommendations follow the American Heart Association/American Stroke Association methods of classifying the level of certainty of the treatment effect and the class of evidence. Prerelease review of the draft guideline was performed by 6 expert peer reviewers and by the members of the Stroke Council Scientific Oversight Committee and Stroke Council Leadership Committee. Results Evidence-based guidelines are presented for the care of patients with acute intracerebral hemorrhage. Topics focused on diagnosis, management of coagulopathy and blood pressure, prevention and control of secondary brain injury and intracranial pressure, the role of surgery, outcome prediction, rehabilitation, secondary prevention, and future considerations. Results of new phase 3 trials were incorporated. Conclusions Intracerebral hemorrhage remains a serious condition for which early aggressive care is warranted. These guidelines provide a framework for goal-directed treatment of the patient with intracerebral hemorrhage.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available